You just read:

RXi Pharmaceuticals Announces Publication in Molecular Therapy on Self-Delivering RNAi (sd-rxRNA®) Targeting PD-1 in Adoptive Cell Therapy for the Treatment of Malignant Melanoma

News provided by

RXi Pharmaceuticals Corporation

Apr 16, 2018, 11:25 ET